Blackstone Strategic Opportunity Associates L.L.C., 10% Owner at Praxis Precision Medicines, Inc. (PRAX), sold 3,000 shares at $15.88 ($48K) on 2021-08-18, disclosed to the SEC on 2021-08-20.
Open-market sale of $48k PRAX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.